Epithelial-Mesenchymal Cell Interactions and Participation of the Neuroendocrine Markers in Tumor Development. Immunohistochemical Study

Archivum Immunologiae et Therapiae Experimentalis

Volumn 46, Issue 4, 1998, Pages 247-251

  Zółtowska, Albina ^a   Stepiński, Jan ^a   Kuczkowski, Jerzy ^a   Kamiński, Maciej ^a   Cynowska, Bogusława ^a   Kruszewski, Wiesław ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Chromogranin A; Epithelial pearls; S100 protein; Stromal environment; Synaptophysin

Indexed keywords

ACTIN; CHROMOGRANIN; CHROMOGRANIN A; PROTEIN S 100; SYNAPTOPHYSIN; TUMOR MARKER;

ARTICLE; CELL COMMUNICATION; COLON TUMOR; CYTOLOGY; EPITHELIUM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MESODERM; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; SALIVARY GLAND TUMOR; STROMA CELL;

ACTINS; CELL COMMUNICATION; CHROMOGRANIN A; CHROMOGRANINS; COLONIC NEOPLASMS; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MESODERM; NEOPLASMS; S100 PROTEINS; SALIVARY GLAND NEOPLASMS; STROMAL CELLS; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0031609440     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. BRUDZYNSKI K. and MARTINEZ W. (1993): Synaptophysin-containing microvesicles transport heat-shock protein (hsp) 60 in insulin-secreting beta cells. Cytotcchnology, 11, 23-33.
2. CZARNECKI J. and JASKÓLSKI B. (1978): Preparation TFX "Polfa" Jelenia Góra. Arch. Immunol. Ther. Exp., 26, 475.
3. EDGREN M., STRIDSBERG M., KALKNAR K. M. and NILSSON S. (1996): Neuroendocrine markers; chromogranin, pancreastatin and serotonin in the management of patients with advanced renal carcinoma. Anticancer Res., 16, 3871-3874.
4. FOLKMAN J. (1995): Clinical application of research on angiogenesis. N. Engl. J. Med., 333, 1757-1763.
5. GARIN-CHESA P., OLD L. Y. and RETTIG W. Y. (1990): Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc. Natl. Acad. Sci. USA, 87, 7235-7239.
6. GRAZIANO S. L., TATUM A. H., NEWMAN N. B., OLER A., KOHMAN L. J., VEIT L. J., GAMBLE G. P., COLEMAN M. J., BARMADA S. and O'LEAR S. (1994): The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Cancer Res., 54, 2908-2913.
7. GREGOIRE M. and LIEUBEAU B. (1995): The role of fibroblasts in tumor behaviour. Cancer Metastatis Rev., 14, 339-350.
8. HAASS N. K., KARTENBECK M. A. and LEUBE R. E. (1996): Pantophysin is a ubiquitously expressed synaptophysin homologue and defines constitutive transport vesicles. J. Cell Biol., 134, 731-746.
9. HALL A. K. (1991): Differential expression of thymosin genes in human tumors and in the developing, human kidney. Int. J. Cancer, 48, 672-677.
10. LOWE A. W., MADEDDU L. and KELLY R. B. (1988): Neuroendocrine secretory granules and neural synaptic vesicles have three integral membrane protein in common. J. Cell Biol., 105, 51-59.
11. OATES K. K. and COSS M. C. (1991): Biochemical and immunohistochemical identification of thymosin alpha-1 in MCF-7 breast cancer cells. Thymus, 17, 147-154.
12. SCALAN M. J., RAJ B. K. M., CALVO B., GARIN-CHESA P., SANZ-MONCASI M. P., HEALEY J. H., OLD L. J. and RETTIG W. J. (1994): Molecular cloning of fibroblast activation protein α, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc. Natl. Acad. Sci. USA, 91, 5657-5661.
13. SCHLEUSENER J. T., TAZELAAR H. D., JUNG S. H., CHA S. S., CERA P. J., MEYERS J. L., CREAGAN E. T., GOLDBERG R. M. and MARSCHKE R. F. JR. (1996): Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma. Cancer, 77, 1284-1291.
14. TSANG W. Y. and CHAN J. K. (1996): Endocrine-ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am. J. Surg. Pathol., 20, 921-943.
15. WELT S., DIVGI R. D., SCOTT A. W., GARIN-CHESA P., FINN R. D., GRAHAM M., CASWELL E. A., COHEN A., LARSEN S. M., OLD L. J. and RETTIG W. J. (1994): Antibody targeting in metastatic colon cancer: A phase I study of monoclonal antibody F19 against a cell surface protein of reactive tumor stromal fibroblasts. J. Clin. Pathol., 12, 1193-1203.
16. WRIGHT N. A. (1990): Endocrine cells in non-endocrine tumors. J. Pathol., 161, 85-87.
17. ŻÓŁTOWSKA A. (1989): Cancer and thymus extract. Arch. Immunol. Ther. Exp., 35, 585-591.
18. ŻÓŁTOWSKA A. (1991): Myoid and epithelial cells differentiation in mysthenic thymuses. Thymus, 17, 237-248.
19. ŻÓŁTOWSKA A. (1997): The pathogenesis of breast carcinoma. Immunohistochemical study. Arch. Immunol. Ther. Exp., 45, 101-104.
20. ŻÓŁTOWSKA A., MOSZKOWSKA G., ZAMORSKA B. and ROSZKIEWICZ A. (1996): Immunohistochemical study in breast carcinoma. S100-protein positive cells and neuroendocrine differentiation. Arch. Immunol. Ther. Exp., 44, 271-277.